{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:08:49Z","timestamp":1788908929264,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02933-9","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:02:05Z","timestamp":1788908525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Highly efficient intranasal H5N1 vaccine based on a safe vesicular stomatitis virus (VSV) vector"],"prefix":"10.1038","volume":"11","author":[{"given":"Ziteng","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-9735","authenticated-orcid":false,"given":"Shuaiyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-8889","authenticated-orcid":false,"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"2933_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/20477724.2021.1878443","volume":"115","author":"A Mercer","year":"2021","unstructured":"Mercer, A. Protection against severe infectious disease in the past. Pathog. Glob. Health 115, 151\u2013167 (2021).","journal-title":"Pathog. Glob. Health"},{"key":"2933_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/v2041002","volume":"2","author":"D Stone","year":"2010","unstructured":"Stone, D. Novel viral vector systems for gene therapy. Viruses 2, 1002\u20131007 (2010).","journal-title":"Viruses"},{"key":"2933_CR3","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1080\/22221751.2020.1830715","volume":"9","author":"H Li","year":"2020","unstructured":"Li, H. et al. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays. Emerg. Microbes Infect. 9, 2269\u20132277 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"2933_CR4","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","volume":"93","author":"MJ Schnell","year":"1996","unstructured":"Schnell, M. J. et al. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA 93, 11359\u201311365 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2933_CR5","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1016\/j.vaccine.2016.06.071","volume":"34","author":"DK Clarke","year":"2016","unstructured":"Clarke, D. K. et al. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk\/benefit assessment. Vaccine 34, 6597\u20136609 (2016).","journal-title":"Vaccine"},{"key":"2933_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/mt.2009.95","volume":"17","author":"JE Boudreau","year":"2009","unstructured":"Boudreau, J. E. et al. Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity. Mol. Ther. 17, 1465\u20131472 (2009).","journal-title":"Mol. Ther."},{"key":"2933_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/22221751.2021.1903343","volume":"10","author":"I Morozov","year":"2021","unstructured":"Morozov, I. et al. High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. Emerg. Microbes Infect. 10, 651\u2013663 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"2933_CR8","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1128\/jvi.70.4.2318-2323.1996","volume":"70","author":"MJ Schnell","year":"1996","unstructured":"Schnell, M. J. et al. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70, 2318\u20132323 (1996).","journal-title":"J. Virol."},{"key":"2933_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14760584.2020.1711054","volume":"19","author":"L Neukirch","year":"2020","unstructured":"Neukirch, L. et al. The potential of adenoviral vaccine vectors with altered antigen presentation capabilities. Expert Rev. Vaccines. 19, 25\u201341 (2020).","journal-title":"Expert Rev. Vaccines."},{"key":"2933_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/vaccines8010064","volume":"8","author":"WE Matchett","year":"2020","unstructured":"Matchett, W. E. et al. Genetic adjuvants in replicating single-cycle adenovirus vectors amplify systemic and mucosal immune responses against HIV-1 envelope. Vaccines. 8, 64 (2020).","journal-title":"Vaccines."},{"key":"2933_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.gene.2005.06.037","volume":"361","author":"M Kozak","year":"2005","unstructured":"Kozak, M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361, 13\u201337 (2005).","journal-title":"Gene"},{"key":"2933_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-04024-2","volume":"21","author":"VE Garcia","year":"2022","unstructured":"Garcia, V. E., Dial, R. & DeRisi, J. L. Functional characterization of 5\u2019 UTR cis-acting sequence elements that modulate translational efficiency in Plasmodium falciparum and humans. Malar. J. 21, 15 (2022).","journal-title":"Malar. J."},{"key":"2933_CR13","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1128\/JVI.01911-06","volume":"81","author":"DK Clarke","year":"2007","unstructured":"Clarke, D. K. et al. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations. J. Virol. 81, 2056\u20132064 (2007).","journal-title":"J. Virol."},{"key":"2933_CR14","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1128\/JVI.75.13.6107-6114.2001","volume":"75","author":"EB Flanagan","year":"2001","unstructured":"Flanagan, E. B. et al. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. J. Virol. 75, 6107\u20136114 (2001).","journal-title":"J. Virol."},{"key":"2933_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","volume":"4","author":"DF Stojdl","year":"2003","unstructured":"Stojdl, D. F. et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell Int. 4, 263\u2013275 (2003).","journal-title":"Cancer Cell Int."},{"key":"2933_CR16","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1007\/s11033-019-04799-3","volume":"46","author":"Z Gray","year":"2019","unstructured":"Gray, Z. et al. M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells. Mol. Biol. Rep. 46, 3371\u20133379 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"2933_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jss.2019.07.032","volume":"245","author":"GL Day","year":"2019","unstructured":"Day, G. L. et al. Immune effects of M51R vesicular stomatitis virus treatment of carcinomatosis from colon cancer. J. Surg. Res. 245, 127\u2013135 (2019).","journal-title":"J. Surg. Res."},{"key":"2933_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00947-4","volume":"9","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. A broad-spectrum vaccine candidate against H5 viruses bearing different sub-clade 2.3.4.4 HA genes. NPJ Vaccines 9, 152 (2024).","journal-title":"NPJ Vaccines"},{"key":"2933_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","volume":"9","author":"DS Raj\u00e3o","year":"2018","unstructured":"Raj\u00e3o, D. S. & P\u00e9rez, D. R. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture. Front. Microbiol. 9, 123 (2018).","journal-title":"Front. Microbiol."},{"key":"2933_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1517\/14728214.13.1.21","volume":"13","author":"PK Tosh","year":"2008","unstructured":"Tosh, P. K. & Poland, G. A. Emerging vaccines for influenza. Exp. Opin. Emerg. Drugs 13, 21\u201340 (2008).","journal-title":"Exp. Opin. Emerg. Drugs"},{"key":"2933_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virol.2007.04.021","volume":"366","author":"JA Schwartz","year":"2007","unstructured":"Schwartz, J. A. et al. Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. Virology 366, 166\u2013173 (2007).","journal-title":"Virology"},{"key":"2933_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0155-z","volume":"5","author":"W Furuyama","year":"2020","unstructured":"Furuyama, W. et al. A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades. NPJ Vaccines 5, 4 (2020).","journal-title":"NPJ Vaccines"},{"key":"2933_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0092-8674(81)90143-4","volume":"23","author":"LE Iverson","year":"1981","unstructured":"Iverson, L. E. & Rose, J. K. Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 23, 477\u2013484 (1981).","journal-title":"Cell"},{"key":"2933_CR24","first-page":"96","volume":"12","author":"DS Goodin","year":"2005","unstructured":"Goodin, D. S. Treatment of multiple sclerosis with human beta interferon. Int. MS J. 12, 96\u2013108 (2005).","journal-title":"Int. MS J."},{"key":"2933_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/sj.cr.7290309","volume":"15","author":"AK Perry","year":"2005","unstructured":"Perry, A. K. et al. The host type I interferon response to viral and bacterial infections. Cell Res. 15, 407\u2013422 (2005).","journal-title":"Cell Res."},{"key":"2933_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2016.09.009","volume":"499","author":"AJ Varble","year":"2016","unstructured":"Varble, A. J. et al. The vesicular stomatitis virus matrix protein inhibits NF-\u03baB activation in mouse L929 cells. Virology 499, 99\u2013104 (2016).","journal-title":"Virology"},{"key":"2933_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molimm.2025.05.021","volume":"184","author":"H Li","year":"2025","unstructured":"Li, H. et al. The effects of tolerogenic dendritic cells on the TLR4\/MyD88\/NF-\u03baB signaling pathway in rats with collagen-induced arthritis. Mol. Immunol. 184, 100\u2013111 (2025).","journal-title":"Mol. Immunol."},{"key":"2933_CR28","doi-asserted-by":"publisher","first-page":"e1002712","DOI":"10.1371\/journal.ppat.1002712","volume":"8","author":"V Fensterl","year":"2012","unstructured":"Fensterl, V. et al. Interferon-induced Ifit2\/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8, e1002712 (2012).","journal-title":"PLoS Pathog."},{"key":"2933_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49597-z","volume":"15","author":"JR Zhang","year":"2024","unstructured":"Zhang, J. R. et al. Augmented microglial endoplasmic reticulum-mitochondria contacts mediate depression-like behavior in mice induced by chronic social defeat stress. Nat. Commun. 15, 5199 (2024).","journal-title":"Nat. Commun."},{"key":"2933_CR30","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1099\/vir.0.023978-0","volume":"91","author":"M Hoffmann","year":"2010","unstructured":"Hoffmann, M. et al. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J. Gen. Virol. 91, 2782\u20132793 (2010).","journal-title":"J. Gen. Virol."},{"key":"2933_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2020.107608","volume":"44","author":"SK Kiesslich","year":"2020","unstructured":"Kiesslich, S. K. et al. Vero cell upstream bioprocess development for the production of viral vectors and vaccines. Biotechnol. Adv. 44, 107608 (2020).","journal-title":"Biotechnol. Adv."},{"key":"2933_CR32","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","volume":"73","author":"A Roberts","year":"1999","unstructured":"Roberts, A. et al. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73, 3723\u20133732 (1999).","journal-title":"J. Virol."},{"key":"2933_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ni.2169","volume":"13","author":"N Honke","year":"2011","unstructured":"Honke, N. et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 13, 51\u201357 (2011).","journal-title":"Nat. Immunol."},{"key":"2933_CR34","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1084\/jem.183.5.2259","volume":"183","author":"MF Bachmann","year":"1996","unstructured":"Bachmann, M. F., Odermatt, B., Hengartner, H. & Zinkernagel, R. M. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183, 2259\u20132269 (1996).","journal-title":"J. Exp. Med."},{"key":"2933_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/vaccines6010016","volume":"6","author":"MM Westcott","year":"2018","unstructured":"Westcott, M. M. et al. Immunogenicity in African green monkeys of M protein mutant vesicular stomatitis virus vectors and contribution of vector-encoded Flagellin. Vaccines 6, 16 (2018).","journal-title":"Vaccines"},{"key":"2933_CR36","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1128\/JVI.00915-08","volume":"82","author":"M Ahmed","year":"2008","unstructured":"Ahmed, M. et al. Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus. J. Virol. 82, 9273\u20139277 (2008).","journal-title":"J. Virol."},{"key":"2933_CR37","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/v6083055","volume":"6","author":"RA Tripp","year":"2014","unstructured":"Tripp, R. A. & Tompkins, S. M. Virus-vectored influenza virus vaccines. Viruses 6, 3055\u20133079 (2014).","journal-title":"Viruses"},{"key":"2933_CR38","doi-asserted-by":"publisher","first-page":"S435","DOI":"10.1093\/infdis\/jiv257","volume":"212","author":"G Wong","year":"2015","unstructured":"Wong, G. et al. Characterization of a bivalent vaccine capable of inducing protection against both Ebola and Cross-clade H5N1 influenza in mice. J. Infect. Dis. 212, S435\u2013S442 (2015).","journal-title":"J. Infect. Dis."},{"key":"2933_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00975-25","volume":"99","author":"B Sownthirarajan","year":"2025","unstructured":"Sownthirarajan, B. et al. A versatile H5N1-VSV platform for safe influenza virus research applications. J. Virol. 99, e0097525 (2025).","journal-title":"J. Virol."},{"key":"2933_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/irv.12080","volume":"7","author":"B Killingley","year":"2013","unstructured":"Killingley, B. & Nguyen-Van-Tam, J. Routes of influenza transmission. Influenza Other Respir. Viruses 7, 42\u201351 (2013).","journal-title":"Influenza Other Respir. Viruses"},{"key":"2933_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2022","unstructured":"Lavelle, E. C. & Ward, R. W. Mucosal vaccines - fortifying the frontiers. Nat. Rev. Immunol. 22, 236\u2013250 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2933_CR42","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1016\/j.cell.2022.11.006","volume":"185","author":"C Le Nou\u00ebn","year":"2022","unstructured":"Le Nou\u00ebn, C. et al. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys. Cell 185, 4811\u20134825.e4817 (2022).","journal-title":"Cell"},{"key":"2933_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2261566","volume":"12","author":"Z Liang","year":"2023","unstructured":"Liang, Z. et al. Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector. Emerg. Microbes Infect. 12, e2261566 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"2933_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2467770","volume":"14","author":"Z Cheng","year":"2025","unstructured":"Cheng, Z. et al. A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization. Emerg. Microbes Infect. 14, 2467770 (2025).","journal-title":"Emerg. Microbes Infect."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02933-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02933-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02933-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:02:06Z","timestamp":1788908526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02933-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2933"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02933-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The animal safety and immunogenicity evaluation of the VSV vector were conducted under the approval of the Institutional Animal Care and Use Committee at the National Institutes for Food and Drug Control (NIFDC). The experiments were approved based on the Guide for the Care and Use of Laboratory Animals (Approval number: 2020(B) 001). Omics analysis of VSV vectors and animal evaluation studies related to H5N1 were approved by the Institutional Animal Care and Use Committee of the IMBCAMS (Approval number.: DWSP20240616001, and strictly followed the guidelines in the ABSL-3 facility of the Kunming National Primate Research Center of High-level Biosafety, Yunnan, China.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"372"}}